Category Archives: cannabis legalization

Hemp fibers can be turned into electrodes capable of better storing energy in super capacitors.


Using cannabis, scientists discover inexpensive way to dramatically boost battery storage potential

Wednesday, September 10, 2014

by: Ethan A. Huff

A plant that is still banned in most of the U.S. offers amazing energy-storage potential that far exceeds anything currently on the market. Researchers presenting at the recent 248th National Meeting & Exposition of the American Chemical Society revealed that fibers from the hemp plant, a variety of the cannabis plant, can be turned into electrodes capable of better storing energy in supercapacitors.
The best material currently available for supercapacitor electrodes is graphene, a light-weight material that is both strong and able to be made thin enough to store high amounts of energy. Scientists have been developing novel ways to utilize graphene in things like batteries, touch-screen smartphones and devices, water filtration systems and solar panels, making these products more efficient and easier to recharge.

Continue reading

Free Marijuana for the homeless & low-income. Berkeley, Calif.

 Unable to afford medication;marijuana

Unable to afford medication;marijuana

“Beginning next August, medical marijuana dispensaries in this city will be required to donate at least 2 percent of their cannabis to low-income residents. The City Council approved the requirement this summer — unanimously no less — with the hope of making the drug, which can sell for up to $400 an ounce at dispensaries, affordable for all residents.”

“The compassion system has now been formalized in Berkeley, where city officials aim to provide low-income patients with a more reliable supply of medical cannabis. Only Berkeley residents are eligible for the free marijuana, and they must show proof of income (less than $32,000 a year for individuals).”

“He added that there was “probably a lot of use of medical marijuana by people who don’t really need it.”

“If the city’s mandate is another step toward legalization for recreational use, Mr. Bates said, then so much the better.”

“I think what we’re seeing now is an evolution towards full legalization,” he said. “It’s coming. It may not be in the next few years, but it’s coming.”


Marijuana legalization challenged by well funded alcohol and beer lobbyists.


Marijuana Legalization: Pharmaceuticals, Alcohol Industry Among Biggest Opponents Of Legal Weed

By Philip
on August 06 2014 5:54 PM

Opposition To Pot Reform = Big Money For Pharmaceuticals

Pancreatic cancer survivor Mellody Gannon smokes medicinal marijuana during the annual convention of the National Organization for the Reform of Marijuana Laws (NORML) in San Francisco, California Sept. 25, 2009.REUTERS/Robert Galbraith

Opponents of marijuana legalization argue that decriminalizing pot increases crime, creates juvenile delinquents and can even lead to more marijuana-related deaths. But there is another reason for the crusade against marijuana that involves some people losing lots of money as the country becomes increasingly pot friendly, according to a recent report from The Nation and astudy by the Center for Responsive Politics.

The biggest players in the anti-marijuana legalization movement are pharmaceutical, alcohol and beer companies, private prison corporations and police unions, all of whom help fund lobby groups that challenge marijuana law reform. In 2010, California Beer and Beverage Distributors funneled $10,000 to Public Safety First, a political action committee, or PAC, that led the opposition to California’s Prop 19. The initiative, if passed, would have legalized recreational marijuana in the state.

Corrections Corporations of America, one of the largest for-profit prison companies in the U.S., has spent nearly $1 million a year on lobbying efforts. The company even stated in a report that “changes with respect to drugs and controlled substances … could affect the number of persons arrested, convicted, and sentenced, thereby potentially reducing demand for correctional facilities to house them.”

Among the largest donors to Partnership for Drug-Free Kids, a New York City-based nonprofit that campaigns against teen drug and alcohol abuse, are Purdue Pharma, makers of the painkiller OxyContin, and Abbott Laboratories, which produces the opioid Vicodin. Community Anti-Drug Coalitions of America, or CADCA, a Virginia-based anti-drug organization, also receives donations from Purdue Pharma, as well as Janssen Pharmaceutical, a subsidiary of Johnson and Johnson that manufactures the painkiller Nucynta, according to The Nation.

The reason for opposing marijuana reform is simple: Legal weed hurts these companies’ bottom lines. “There is big money in marijuana prohibition,” the Center for Responsive Politics, a non-profit research group based in Washington, D.C., notes in a recent series on marijuana lobbying efforts, including who funds legislation to keep the drug illegal.

Part of the missions of groups like Partnership for Drug-Free Kids and CADCA is to lobby Congress to maintain marijuana’s classification as a Schedule 1 drug, meaning the U.S. government considers the drug as having a high potential for abuse, has no medical use and poses risks to public safety. Nevermind that more than 22,000 people die every year in the U.S. from overdoses involving pharmaceutical drugs, according to the Centers for Disease Control and Prevention. Three out of every four pharmaceutical overdose deaths involve painkillers — more than heroin and cocaine combined.

“I think it’s hypocritical to remain silent with regard to the scheduling of hydrocodone products, while investing energy in maintaining marijuana as a Schedule I drug,” Andrew Kolodny, a New York psychiatrist and head of Physicians for Responsible Opioid Prescribing, told The Nation. “I don’t think it’s inappropriate for them to be advocating on marijuana, [but] when we have a severe epidemic in America — one the CDC says is the worst drug epidemic in US history — it makes you wonder whether or not they’ve been influenced by their funding.”

The idea is that drug companies want to sell expensive drugs by downplaying the medical benefits of marijuana, alcohol and beer manufacturers do not want to compete for customers with legal pot, and private prisons need to fill their beds with convicted drug offenders. That means marijuana advocates have some pretty large — and well-funded — enemies to contend with.